"The campaign underscores how truck owners are essentially dumping cash all over America's highways from all the hidden costs required in maintaining a private fleet," Ryder's Karen Jones tells"Marketing Daily."
NYS Entity Status
NYS Filing Date
NOVEMBER 21, 2013
NYS DOS ID#
NYS Entity Type
FOREIGN BUSINESS CORPORATION
2013 - A, R & T ARCHITECTS, INC.
Around the Web
- Ryder Trucks Launches Campaign With 'Inc.'
Tuesday Sep 19, 2017
- DataCamp Nabs $4M for Data Science Courses, Moves to NY
By Jeff Engel - Thursday Jul 27, 2017
Data scientists remain in high demand. But these days, many types of professionals can boost their career prospects if they have at least a basic level of “data literacy,” says Jonathan Cornelissen. That’s part of the reason why he says his online education company, DataCamp, has been growing over the past couple of years. DataCamp, […]
- Architects of Social Responsibility: Views of Humanitarian Architecture in Practice
By Jason Schneiderman - Tuesday Jun 6, 2017
What is the role of architecture in civil society, and how has the field’s involvement in humanitarian work changed the profession?
- Reviving the Joy of Decoration at Nike’s New SoHo Building
By BLAKE GOPNIK - Sunday Oct 1, 2017
With a nod to a more ornate past, a new structure designed by BKSK Architects at 529 Broadway belongs entirely to the present.
- Fake Architect Sentenced In ‘Vandelay Industries’ Investigation
By Laura Northrup - Tuesday Sep 5, 2017
If someone is a successful architect, people assume that he or she actually is an architect. Yet a man in upstate New York who drew up renderings of over 100 buildings and received hundreds of thousands of dollars in payments for designing commercial and residential buildings has been charged with pretending to be an architect for more than half a …
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]